LOCK HAVEN - As part of the ongoing, continuing medical education programs for the medical staff at Lock Haven Hospital, board certified oncologist/hematologist Vijay Sandilya, M.D. delivered a presentation entitled, "Transfusion Medicine."
Dr. Sandilya offered an overview of the ABO Blood Group System, compatibility, the make up of blood and the difference between type and screen, and type and cross identification. Sandilya detailed medical studies on the risks versus benefits of blood transfusions.
He outlined the work of the New Jersey Institute of Bloodless Medicine and Surgery. Bloodless medicine means surgery or treatment performed without transfusion of allogeneic (donated) blood, but utilizes autologous transfusion of the patient's own blood or blood components.
From left, Maria Bermudez, M.D.; Vijay Sandilya, M.D.; and Carrie Timko, M.D. following Dr. Sandilya’s CME presentation to the Lock Haven Hospital medical staff.
"Having a fellowship-trained physician in the specialty areas of hematology and oncology close to home is of great benefit to patients in the Lock Haven community," said John Zidansek, chief executive officer, Lock Haven Hospital. "Dr. Sandilya's presentation demonstrates the important role he can play in partnership with primary care physicians."
Hematology is the branch of internal medicine that includes the study of blood, blood-forming organs and blood diseases. Oncology involves the diagnosis and treatment of cancer patients.
Dr. Sandilya is fellowship-trained in hematology and oncology at Drexel University College of Medicine, where he also served his residency.
Sandilya is board certified in oncology and hematology by the American Board of Internal Medicine.
Dr. Sandilya is accepting new patients and will be available for hospital and nursing home consultations. Dr. Sandilya provides out-patient chemotherapy based locally at Bald Eagle Court, 1 Outlet Lane, Suites 304 & 305 in McElhattan. The office can be reached at 769-6799.